Tirzepatide Explained: Uses, Safety and How to Get It

By the ShopMedRx team. This article is for general information only and is not medical advice. It is written for adults 18 and older.

Tirzepatide is a once-weekly injectable prescription medicine that acts on two hormone receptors, GIP and GLP-1.^[1] FDA-approved tirzepatide products are labeled for adults with type 2 diabetes, for weight management in certain adults with obesity or overweight, and for moderate to severe obstructive sleep apnea in adults with obesity.^[2][3] It is available only by prescription, and a licensed clinician has to decide whether it is appropriate for you.

Is tirzepatide a prescription drug? What it is and how it works

Yes. Tirzepatide is prescription-only. It is given as an injection under the skin once a week, and the dose is raised step by step over several months.^[1]

It is called a dual GIP and GLP-1 receptor agonist.^[1] In plain words, it activates receptors for two gut hormones that are involved in blood sugar and appetite. The FDA label also notes that tirzepatide slows how quickly the stomach empties. That effect is largest after the first dose and fades over time.^[2]

For weight management, the label says the medicine is used together with a reduced-calorie diet and more physical activity, not instead of them.^[2] If you want to know how eating habits fit in, our guide to what to eat on a GLP-1 medicine covers it.

Tirzepatide for type 2 diabetes, weight management and sleep apnea

Different FDA-approved tirzepatide products carry different labeled uses. This table summarizes what the labels say. It does not describe what any compounded medication is approved for, because compounded medications are not FDA-approved.

Use	What the FDA label says
Type 2 diabetes	Used with diet and exercise to improve blood sugar control in adults and in children 10 and older. Also labeled to lower the risk of major cardiovascular events in adults with type 2 diabetes who are at high risk.[4]
Weight management	Used with a reduced-calorie diet and more activity to reduce excess body weight and keep it off long term in adults with obesity, or with overweight plus at least one weight-related condition.[2]
Obstructive sleep apnea	Used to treat moderate to severe obstructive sleep apnea in adults with obesity.[2]

What about tirzepatide for type 2 diabetes?

If you have type 2 diabetes, your diabetes care team should stay involved in any decision about tirzepatide. The label warns that blood sugar can drop too low when the medicine is combined with insulin or a sulfonylurea, and doses of those medicines may need to change.^[5] Never adjust diabetes medicines on your own. Tell any clinician who reviews your health assessment about every medicine you take.

What clinical trials found about tirzepatide

The main weight-management trial for FDA-approved tirzepatide, called SURMOUNT-1, lasted 72 weeks and enrolled adults with obesity. The average change in body weight at week 72 was a 15.0% reduction with 5 mg weekly, 19.5% with 10 mg and 20.9% with 15 mg. People who received placebo had an average reduction of 3.1%.^[6] Individual results vary.

The most common side effects in that trial were digestive. Most were mild to moderate and happened mainly while the dose was being raised. Side effects led some people to stop treatment: 4.3% in the 5 mg group, 7.1% in the 10 mg group and 6.2% in the 15 mg group, compared with 2.6% on placebo.^[6]

An important limit: these results come from studies of FDA-approved tirzepatide. Compounded medications have not been studied in the same way, so the numbers above should not be assumed to apply to them.

Tirzepatide dosing: how the label schedule works

The FDA label for tirzepatide for weight management and sleep apnea sets out a slow ramp-up:

• The starting dose is 2.5 mg once a week for 4 weeks.^[7]
• After 4 weeks, the dose goes up to 5 mg once a week.^[2]
• Further increases come in 2.5 mg steps, with at least 4 weeks on each dose.^[7]
• Maintenance doses for weight management are 5 mg, 10 mg or 15 mg weekly. For sleep apnea they are 10 mg or 15 mg. The maximum is 15 mg weekly.^[7]
• The label says to weigh how well the dose is working against how well it is tolerated when choosing a maintenance dose.^[7]

The schedule exists to give the body time to adjust. Your clinician sets your actual dose and decides whether any change is needed. Do not raise a dose faster than you were told, and ask before you skip, double or stop a dose.

Dosing matters even more with compounded products. The FDA has identified dosing errors, unapproved salt forms and adverse events that sometimes needed hospital care among compounded versions of tirzepatide and semaglutide.^[8] If the instructions you receive are unclear, call your clinician or pharmacy before using the medicine.

Tirzepatide safety: boxed warning, who should not use it and side effects

Tirzepatide has a boxed warning, the FDA's most serious type. It says tirzepatide causes thyroid C-cell tumors in rats and that it is not known whether it does so in people. It should not be used by anyone with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).^[9] People are told to report a lump in the neck, hoarseness that does not go away, trouble swallowing or shortness of breath.^[9]

Risk	What the label and drug references say	What to do
Thyroid tumors	Boxed warning based on rat studies; human relevance not determined.[9]	Tell your clinician about any personal or family history of MTC or MEN 2. Report neck lumps or voice changes.
Pancreatitis	Can cause persistent or severe abdominal pain, sometimes spreading to the back, with or without nausea or vomiting.[5]	Stop the medicine and get medical care right away.
Gallbladder problems	Can include gallstones and gallbladder inflammation.[10]	Report upper stomach pain or fever.
Low blood sugar	Risk is higher when used with insulin or a sulfonylurea.[5]	Ask whether your other diabetes medicines need adjusting.
Dehydration and kidney injury	Kidney injury has been reported, most often after nausea, vomiting or diarrhea caused dehydration.[5]	Drink fluids and call your clinician if you cannot keep fluids down.
Allergic reactions	Serious reactions such as anaphylaxis and angioedema have been reported.[5]	Stop the medicine and seek medical care.

The most common side effects, reported by at least 5% of people in the diabetes label's trials, were nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion and abdominal pain.^[5] Tirzepatide is also not recommended for people with severe slowed stomach emptying (gastroparesis).^[10]

If you have severe belly pain, signs of an allergic reaction, or symptoms of very low blood sugar, get urgent medical help. Tell your clinician if you are pregnant, planning a pregnancy or breastfeeding, and share a full list of your medicines and supplements.

Tirzepatide brand names and compounded tirzepatide

FDA-approved tirzepatide is sold by its manufacturer under two brand names. One is labeled for type 2 diabetes, and the other is labeled for weight management and sleep apnea.^[4] We do not print brand names in this article. If you see a name on a box or pharmacy label, ask your pharmacist whether the product is FDA-approved or compounded.

Most ShopMedRx medicines, including tirzepatide, are compounded by licensed U.S. partner pharmacies after a clinician prescribes them. Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness or quality before they are marketed.^[8] The FDA says a compounded drug might be appropriate when a patient's medical need cannot be met by an approved drug, or when the approved drug is not commercially available.^[8] Whether that applies to you is a clinician's decision.

How to get tirzepatide through telehealth

Getting tirzepatide always involves a licensed prescriber. Here is how it works at ShopMedRx:

1. You complete an online health assessment about your history, conditions and current medicines.
2. An independent, licensed clinician from our care partner OpenLoop Health reviews it. The clinician may ask follow-up questions, may decide a prescription is not appropriate, or may suggest you see your own doctor in person.
3. If a prescription is appropriate, a licensed U.S. partner pharmacy prepares and ships it.
4. You follow your clinician's instructions and report side effects. Dose changes happen only on clinician advice.

Approval is never guaranteed, and there is no way to skip the clinical review. You can read more about the tirzepatide injection program before you decide whether to start an assessment.

Red flags to watch for with any online provider

The FDA lists warning signs for telehealth companies selling GLP-1 medicines. Walk away if a company:^[8]

• claims a compounded drug matches an FDA-approved drug;
• offers medicine at prices that seem too good to be true;
• does not require screening and a prescription from a licensed doctor;
• sends medicine that looks different from what was pictured, or in damaged packaging with no instructions.

The FDA has also received complaints that some injectable GLP-1 products arrived warm or poorly cooled.^[11] Read the storage instructions, check the package when it arrives and ask your pharmacy before using anything that seems off.

Is there a best tirzepatide? Questions to ask a clinician

There is no single best tirzepatide for everyone. The right choice depends on why you are considering it, your health history, your other medicines and how you tolerate treatment. A clinician is the right person to weigh those factors, including whether an FDA-approved product or a compounded medication fits your situation.

Bring these questions to your visit:

• Is tirzepatide appropriate for me given my medical and family history, especially thyroid conditions?
• Does anything I take, such as insulin or a sulfonylurea, need to be adjusted?
• Is this product FDA-approved or compounded, and what does that mean for me?
• What dose will I start on, how will it change, and who do I call about side effects?
• How will we decide if the medicine is working and whether to continue?
• Should we talk about other GLP-1 options, such as semaglutide injections?

Frequently asked questions

Is tirzepatide approved for type 2 diabetes?

One FDA-approved tirzepatide product is labeled for adults with type 2 diabetes, and for children 10 and older, as an add-on to diet and exercise.^[4] Compounded medications are not FDA-approved for any use. A clinician decides what is appropriate for you.

Do I need a prescription for tirzepatide?

Yes. Tirzepatide is prescription-only. Be cautious of any website that offers it without a screening and a prescription from a licensed clinician, since the FDA lists that as a red flag.^[8]

Who should not take tirzepatide?

People with a personal or family history of medullary thyroid carcinoma or MEN 2 should not use it.^[9] People with severe gastroparesis, a history of pancreatitis or gallbladder disease, or who use insulin or a sulfonylurea need extra care and a clinician's guidance.^[10]

Is compounded tirzepatide FDA-approved?

No. The FDA says compounded drugs are not FDA-approved and are not reviewed for safety, effectiveness or quality before marketing.^[8] They are prepared by licensed pharmacies on a clinician's prescription.

What are the common side effects of tirzepatide?

The most common are nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion and abdominal pain.^[5] They tend to appear while the dose is being increased.^[6] Call your clinician if they are severe or do not settle.

How does getting tirzepatide through telehealth work?

You complete an online health assessment, and an independent licensed clinician reviews it and decides if a prescription is appropriate. If one is written, a licensed partner pharmacy fills it. Approval is not guaranteed.

Talk to a licensed clinician

Tirzepatide can be a serious medicine with real risks, and the right decision depends on your health history. A licensed clinician can review your answers, explain the options and tell you if a prescription is appropriate. Talk to a clinician before you start, stop or change any treatment.

Check if you qualify

Important information

• This article is for general education and is not medical advice. Talk to a licensed clinician before starting, stopping or changing any treatment.
• All medications available through ShopMedRx are prescription only and are prescribed only if appropriate after a licensed clinician's review.
• Some medications we offer are compounded. Compounded medications are not FDA-approved, and the FDA does not review compounded drugs for safety, effectiveness or quality before they are marketed. They are not the same as, or generic versions of, brand-name drugs.
• Individual results vary. Nothing in this article promises a specific result.
• Prescriptions are written by independent, licensed clinicians through OpenLoop Health and filled by licensed U.S. partner pharmacies.

Sources

1. Qin W, et al. Tirzepatide for weight management: systematic review and meta-analysis including SURMOUNT-2. Endocrine, 2024. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11445313/ (describes tirzepatide as a dual GIP and GLP-1 receptor agonist and its once-weekly use). See also: Early-onset obesity and tirzepatide treatment, post hoc analysis of the SURMOUNT trials. PubMed Central, 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12381612/
2. Eli Lilly and Company. Tirzepatide injection for weight reduction and obstructive sleep apnea: prescribing information. U.S. FDA, 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/217806s031lbl.pdf
3. Same label as source 2: indications and usage. U.S. FDA, 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/217806s031lbl.pdf
4. Drugs.com. Tirzepatide overview: approved uses and dosing. Drugs.com, accessed October 2026. https://www.drugs.com/tirzepatide.html
5. Eli Lilly and Company. Tirzepatide injection for type 2 diabetes: label information (warnings, adverse reactions). DailyMed, National Library of Medicine, accessed October 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0
6. Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 2022. https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
7. Eli Lilly and Company. Tirzepatide injection for weight reduction and obstructive sleep apnea: prescribing information, 2026 revision. U.S. FDA, 2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217806s002lbl.pdf
8. U.S. Food and Drug Administration. FDA's concerns with unapproved GLP-1 drugs used for weight loss. U.S. FDA, 2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss (dosing errors, unapproved salt forms and hospitalizations are also described in: U.S. FDA. FDA launches green list to protect Americans from illegal imported GLP-1 drug ingredients. https://www.fda.gov/news-events/press-announcements/fda-launches-green-list-protect-americans-illegal-imported-glp-1-drug-ingredients)
9. Eli Lilly and Company. Tirzepatide injection for type 2 diabetes: prescribing information, boxed warning. DailyMed, National Library of Medicine, accessed October 2026. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0
10. RxList. Tirzepatide: side effects, uses, dosage, interactions, warnings. RxList, 2026. https://www.rxlist.com/tirzepatide/generic-drug.htm
11. Pharmacy Times. FDA moves to restrict mass-marketed compounded GLP-1 products. Pharmacy Times, 2026. https://www.pharmacytimes.com/view/fda-moves-to-restrict-mass-marketed-compounded-glp-1-products